Excelsoft IPO
Excelsoft IPO
Excelsoft Technologies Limited is a global vertical SaaS company specializing in secure, cloud-based technology solutions for the learning and assessment market. The company offers two main platforms: **Assessment Solutions** (Saras eAssessment and easyProctor for high-stakes exams) and **Learning Solutions** (SARAS LMS, EnablED, and OpenPage for interactive content). It serves certification bodies, universities, publishers, and corporates globally, including major clients like Pearson Professional Assessments and AQA Education. The company operates with an asset-light, scalable, and innovation-driven model, backed by ISO 27001 and ISO 9001 certifications.
Investment Timeline
🤖 Smart Analysis
*AI score is algorithmic and for educational purposes only.
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
⏰ Apply by DAY 2 NOON - High demand, good allotment still possible
Key Factor Analysis
Issue Details
Object of the Issue
The company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Funding of capital expenditure for purchase of land and construction of new building at the Mysore Property (₹71.97 Cr).
- Funding expenditure for upgradation including external electrical systems of our Existing Facility at Mysore, India (₹39.51 Cr).
- Funding upgradation of our Company’s IT Infrastructure (Software, Hardware and Communications & Network Services) (₹54.64 Cr).
- General Corporate Purposes.
Frequently Asked Questions
What is the current GMP of Excelsoft IPO?
What is the AI Prediction for Excelsoft IPO?
When will the allotment for Excelsoft IPO be announced?
What is the listing date for Excelsoft IPO?
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.